These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6702416)

  • 1. Increased fragility of erythrocytes from amyotrophic lateral sclerosis (ALS) patients provoked by mechanical stress.
    Ronnevi LO; Conradi S
    Acta Neurol Scand; 1984 Jan; 69(1):20-6. PubMed ID: 6702416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies on the erythrocyte uptake of lead in vitro in amyotrophic lateral sclerosis (ALS) patients and controls. Abnormal erythrocyte fragility in ALS.
    Ronnevi LO; Conradi S; Nise G
    J Neurol Sci; 1982; 57(1):143-56. PubMed ID: 6818331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature and properties of cytotoxic plasma activity in amyotrophic lateral sclerosis.
    Ronnevi LO; Conradi S; Karlsson E; Sindhupak R
    Muscle Nerve; 1987 Oct; 10(8):734-43. PubMed ID: 3683447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease.
    Babu GN; Kumar A; Chandra R; Puri SK; Singh RL; Kalita J; Misra UK
    Neurochem Int; 2008 May; 52(6):1284-9. PubMed ID: 18308427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic activity in the plasma of amyotrophic lateral sclerosis (ALS) patients against normal erythrocytes. Quantitative determinations.
    Conradi S; Ronnevi LO
    J Neurol Sci; 1985 May; 68(2-3):135-45. PubMed ID: 4009202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osmotic haemolysis in amyotrophic lateral sclerosis.
    Galli S; Sessa A; Pirotta G; De Caro L; Poloni M; Mazzini L; Pinelli P
    Adv Exp Med Biol; 1987; 209():135-7. PubMed ID: 3577901
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxic activity in plasma from patients with amyotrophic lateral sclerosis.
    Overgaard K; Werdelin L; Sørensen H; Mogensen P; Boysen G
    Neurology; 1991 Jun; 41(6):925-7. PubMed ID: 2046943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum protein binding of lead in vitro in amyotrophic lateral sclerosis patients and controls.
    Conradi S; Ronnevi LO; Stibler H
    J Neurol Sci; 1978 Jun; 37(1-2):95-105. PubMed ID: 690666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma amino acid levels in patients with amyotrophic lateral sclerosis.
    Iwasaki Y; Ikeda K; Kinoshita M
    J Neurol Sci; 1992 Feb; 107(2):219-22. PubMed ID: 1564521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine adenosyltransferase activity in erythrocytes and spinal cord of patients with sporadic amyotrophic lateral sclerosis.
    Ekegren T; Askmark H; Aquilonius SM; Gomes-Trolin C
    Exp Neurol; 1999 Aug; 158(2):422-7. PubMed ID: 10415148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for peripheral immune activation in amyotrophic lateral sclerosis.
    Chen X; Feng W; Huang R; Guo X; Chen Y; Zheng Z; Shang H
    J Neurol Sci; 2014 Dec; 347(1-2):90-5. PubMed ID: 25312013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble OX40 in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Clin Croat; 2012 Mar; 51(1):3-7. PubMed ID: 22919996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma TGF-beta1 in patients with amyotrophic lateral sclerosis.
    Houi K; Kobayashi T; Kato S; Mochio S; Inoue K
    Acta Neurol Scand; 2002 Nov; 106(5):299-301. PubMed ID: 12371924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of erythrocyte biomarkers in amyotrophic lateral sclerosis.
    Lima C; Pinto S; Napoleão P; Pronto-Laborinho AC; Barros MA; Freitas T; de Carvalho M; Saldanha C
    Clin Hemorheol Microcirc; 2016 Oct; 63(4):423-437. PubMed ID: 27258202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of altered aspartyl residues in erythrocyte membrane proteins from patients with sporadic amyotrophic lateral sclerosis.
    D'Angelo S; Trojsi F; Salvatore A; Daniele L; Raimo M; Galletti P; Monsurrò MR
    Neurochem Int; 2013 Nov; 63(6):626-34. PubMed ID: 24044898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma and erythrocyte lipids in amyotrophic lateral sclerosis].
    Maciejek Z; Jazdzewski B; Nicpoń K; Ochmański S
    Neurol Neurochir Pol; 1988; 22(5):387-93. PubMed ID: 3249611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of cardiac troponin T in patients with amyotrophic lateral sclerosis.
    Mach L; Konecny T; Helanova K; Jaffe AS; Sorenson EJ; Somers VK; Reeder GS
    Acta Neurol Belg; 2016 Dec; 116(4):557-564. PubMed ID: 26801485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Total magnesium in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis].
    Iłzecka J; Stelmasiak Z; Kot A
    Neurol Neurochir Pol; 2000; 34(4):699-706. PubMed ID: 11105302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry.
    Conradi S; Ronnevi LO; Vesterberg O
    J Neurol Neurosurg Psychiatry; 1978 May; 41(5):389-93. PubMed ID: 77896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.